Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Untreated alcohol use disorder in people who inject drugs (PWID) in France: a major barrier to HCV treatment uptake (the ANRS‐FANTASIO study)
Tangui Barré, Fabienne Marcellin, Vincent Di Beo, et al.
Addiction (2019) Vol. 115, Iss. 3, pp. 573-582
Open Access | Times Cited: 23

Showing 23 citing articles:

The stigma of alcohol-related liver disease and its impact on healthcare
Georg Schomerus, Anya Leonhard, Jakob Manthey, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 2, pp. 516-524
Open Access | Times Cited: 102
Food inequity and insecurity and MASLD: burden, challenges, and interventions
Shira Zelber‐Sagi, Patrizia Carrieri, Juan M. Pericàs, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 10, pp. 668-686
Closed Access | Times Cited: 8
Prevalence and predictors of no lifetime utilization of mental health treatment among people with mental disorders in France: findings from the ‘Mental Health in General Population’ (MHGP) survey
Hélène Font, Jean‐Luc Roelandt, Hélène Behal, et al.
Social Psychiatry and Psychiatric Epidemiology (2018) Vol. 53, Iss. 6, pp. 567-576
Closed Access | Times Cited: 31
Real‐world economic burden of hepatitis C and impact of direct‐acting antivirals in France: A nationwide claims data analysis
Laurent Lam, Patrizia Carrieri, Gilles Hejblum, et al.
Liver International (2024) Vol. 44, Iss. 5, pp. 1233-1242
Open Access | Times Cited: 2
Low hepatitis C virus-viremia prevalence yet continued barriers to direct-acting antiviral treatment in people living with HIV in the Netherlands
Cas J. Isfordink, Colette Smit, Anders Boyd, et al.
AIDS (2022) Vol. 36, Iss. 6, pp. 773-783
Closed Access | Times Cited: 11
Hepatitis C virus: A critical approach to who really needs treatment
Elias Kouroumalis, Argyro Voumvouraki
World Journal of Hepatology (2022) Vol. 14, Iss. 1, pp. 1-44
Open Access | Times Cited: 9
Biomarkers of Innate Immunity and Immunological Susceptibility to Viral Infection in Patients with Alcoholic Cirrhosis
Isabel Legáz, Elena Navarro‐Noguera, Aurelia Collados-Ros, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 336-336
Open Access | Times Cited: 1
Severe liver fibrosis in the HCV cure era: Major effects of social vulnerability, diabetes, and unhealthy behaviors
Patrizia Carrieri, Fabrice Carrat, Vincent Di Beo, et al.
JHEP Reports (2022) Vol. 4, Iss. 6, pp. 100481-100481
Open Access | Times Cited: 6
Life after hepatitis C cure in HIV‐infected people who inject drugs and men who have sex with men treated with direct‐acting antivirals in France: Health perceptions and experiences from qualitative and quantitative findings (ANRS CO13 HEPAVIH)
Marion Mora, Trevor Goodyear, Fabienne Marcellin, et al.
Journal of Viral Hepatitis (2020) Vol. 27, Iss. 12, pp. 1462-1472
Open Access | Times Cited: 8
Late presentation for HCV care: Time to target people with diabetes and/or hazardous alcohol use (ANRS CO22 HEPATHER cohort)
Mélina Santos, Camélia Protopopescu, Elizabeth Delarocque‐Astagneau, et al.
Liver International (2021) Vol. 42, Iss. 1, pp. 38-49
Closed Access | Times Cited: 7
Impaired health-related quality of life in the HCV cure era: who is concerned? (ANRS CO22 HEPATHER French cohort)
Patrizia Carrieri, Marc Bourlière, Vincent Di Beo, et al.
Quality of Life Research (2023) Vol. 32, Iss. 12, pp. 3427-3438
Closed Access | Times Cited: 2
Falling treatment uptake in the hepatitis C care cascade is a growing threat to achieving elimination
Kathleen Bryce, Colette Smith, Alison Rodger, et al.
Journal of Viral Hepatitis (2022) Vol. 30, Iss. 1, pp. 46-55
Open Access | Times Cited: 4
Hazardous Alcohol Use and Its Effect on Direct-Acting Antiviral Therapy Initiation among People with Active Injection Drug Use and Current Hepatitis C Infection
Hamidreza Karimi‐Sari, Gregory M. Lucas, Katie Zook, et al.
Viruses (2024) Vol. 16, Iss. 9, pp. 1416-1416
Open Access
ADHERE: a toolkit for retaining PWID living with hepatitis C in healthcare systems
Ricardo Baptista‐Leite, Henrique Lopes, Diogo Franco, et al.
Journal of Public Health (2024)
Open Access
HCV Treatment Outcomes in PWID: Impact of Addiction History on SVR12
Ivana Milošević, Branko Beronja, Ana Filipović, et al.
Microorganisms (2024) Vol. 12, Iss. 12, pp. 2554-2554
Open Access
Adherence to opioid agonist therapy predicts uptake of direct-acting antivirals in people who use drugs: results from the French national healthcare database (the ANRS FANTASIO study)
Benjamin Rolland, C. Lions, Vincent Di Beo, et al.
Harm Reduction Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 2
History of alcohol use does not predict HCV direct acting antiviral treatment outcomes
Chisom Ifeoma Adaeze Okwor, Yelena Petrosyan, Craig R. Lee, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada (2022) Vol. 7, Iss. 3, pp. 233-241
Open Access | Times Cited: 1
Management of Hepatitis B in Persons Who Inject Drugs (PWID)
Shang‐Chin Huang, Jia‐Horng Kao
Current Hepatology Reports (2021) Vol. 20, Iss. 4, pp. 158-165
Closed Access | Times Cited: 1
Hepatitis C virus cure from direct‐acting antivirals and mortality: Are people with and without a history of injection drug use in the same boat? (ANRS CO22 Hepather cohort)
Tangui Barré, Marc Bourlière, Lucia Parlati, et al.
Drug and Alcohol Review (2023) Vol. 43, Iss. 3, pp. 718-731
Open Access
Commentary on Barréet al. (2020): Identifying remaining barriers to hepatitis C treatment in the DAA era
Rachel Sacks‐Davis, Daniela K van Santen, Joseph Doyle
Addiction (2019) Vol. 115, Iss. 3, pp. 583-584
Open Access
Time on opioid agonist therapy predicts HCV treatment uptake in people who use drugs: a historical cohort based on French national healthcare database, 2012-2017 (the ANRS FANTASIO project)
Benjamin Rolland, C. Lions, Vincent Di Beo, et al.
Research Square (Research Square) (2022)
Open Access
What barriers delay treatment in patients with hepatitis C?
Crosby
The Journal of Family Practice (2022) Vol. 71, Iss. 7
Open Access
Remaining challenges for hepatitis C virus elimination in the era of direct-acting antiviral agents
Cas Joos Isfordink
(2022)
Open Access
Page 1

Scroll to top